fbpx

SIMRIS ALG

INSPIRED BY NATURE
Simris Alg is a biotechnology company. The company is focused on research and development as well as the production of bioactive substances from cultured microalgae, for applications in nutrition, cosmeceuticals and pharmaceuticals. The company’s technology also replaces unsustainable raw materials from endangered species and sensitive marine ecosystems. The first product is omega-3 supplements that are sold under our own brand. Simris Alg was founded in 2011 and is headquartered in Hammenhög.

RESEARCH

Simris Alg
johan@emergers.se

”Nya värdeströmmar från alganläggningen”

Vid sidan av Simris framgångar med omega-3-tillskott på nyckelmarkanden USA ger inträdet av internationella skönhetsveteranen Schapera en tydlig fingervisning om potentialen i arbetet att utveckla nya värdeströmmar från bolagets alger.

READ HERE
johan@emergers.se

Broader portfolio paves the way for revaluation of Simris stock

Following its major breakthrough with omega-3 products in the United States, Simris is harvesting the initial results of development efforts in its second vertical, cosmeceuticals. The company is also evaluating a number of exciting pharmacological applications, and now that it has reinforced its finances, the way is paved for a revaluation of the share.

READ HERE

ABOUT SIMRIS ALG

CEO: Julian Read

TICKER: SIMRIS B

LIST: First North

WEB: https://simrisalg.se/ 

ANALYSTS

Johan Widmark johan@emergers.se +46739196641

Be first to read new research on growth stocks